#VirBiotech intent on burning through $1B in cash over next 2 years frankly is #obscene.
Any reasonable grounded Co w/ that type of cash would extend the cash runway into 2028, if not 2029...just to be sure.
Any reasonable grounded Co w/ that type of cash would extend the cash runway into 2028, if not 2029...just to be sure.
May 28, 2025 at 8:53 PM
#VirBiotech intent on burning through $1B in cash over next 2 years frankly is #obscene.
Any reasonable grounded Co w/ that type of cash would extend the cash runway into 2028, if not 2029...just to be sure.
Any reasonable grounded Co w/ that type of cash would extend the cash runway into 2028, if not 2029...just to be sure.
#pharmalicensingdeals #pharmaceuticalassets #VirBiotech #Vir #HarbourBioMed #UnnaturalProducts #Genhouse #CSL #Astellas #SolsticeOncology #antiCTLA4antibody #Novartis #UnnaturalProducts #macrocyclicpeptidedrugs #GileadSciences #syntheticlethality #GenhouseBio #Arcellx #EliLilly
zurl.co/HOdjt
zurl.co/HOdjt
Astellas bets on Vir cancer drug, and other licensing deals
Our latest round-up of pharma licensing deals features assets from Vir Biotech, Harbour BioMed, Unnatural Products, Genhouse, and CSL.
zurl.co
February 25, 2026 at 12:05 PM
Our latest round-up of #pharmalicensing deals features assets from #VirBiotech, #HarbourBioMed, #UnnaturalProducts, #Genhouse, and #CSL.
pharmaphorum.com/news/astella...
pharmaphorum.com/news/astella...
February 25, 2026 at 10:59 AM
Our latest round-up of #pharmalicensing deals features assets from #VirBiotech, #HarbourBioMed, #UnnaturalProducts, #Genhouse, and #CSL.
pharmaphorum.com/news/astella...
pharmaphorum.com/news/astella...